Aurobindo is an India-based company that develops and commercializes generic and active pharmaceutical ingredients for the healthcare sector...
Read moreAurobindo is an India-based company that develops and commercializes generic and active pharmaceutical ingredients for the healthcare sector...
Read moreManaging Director
K.Nithyananda Reddy
1986
PublicIndependent CompanyNational Stock Exchange of IndiaAUROPHARMA
Annual Revenue
$3.1B
Aurobindo's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 9B. Over the last four quarters, Aurobindo's revenue has grown by 10.4%. Specifically, in Q1 2022's revenue was $775.6M; in Q2 2022, it was $353.3M; in Q2 2022, it was $795.8M; in Q3 2022, Aurobindo's revenue was $702.8M.